Evidence map›Paper›PMID 28031870›Full record

ReviewFuture science OA2015

Unraveling protein misfolding diseases using model systems.

Sara Peffer, Kimberly Cope, Kevin A Morano

Abstract readReview
In one paragraph

Review in Future science OA, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Protein misfolding diseases.Future science OA · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sara PefferUniversity of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA; University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
Kimberly CopeUniversity of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA; University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
Kevin A MoranoDepartment of Microbiology & Molecular Genetics, University of Texas Medical School, Houston, TX 77030, USA; Department of Microbiology & Molecular Genetics, University of Texas Medical School, Houston, TX 77030, USA.

Funding

Hsp110 protein chaperone function in yeastR01GM074696 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MORANO, KEVIN ANTHONY · 2006 to 2015
$2.8M
NIGMS NIH HHS R01 GM074696
6 · The paper itself

Abstract

Experimental model systems have long been used to probe the causes, consequences and mechanisms of pathology leading to human disease. Ideally, such information can be exploited to inform the development of therapeutic strategies or treatments to combat disease progression. In the case of protein misfolding diseases, a wide range of model systems have been developed to investigate different aspects of disorders including Huntington's disease, Parkinson's disease, Alzheimer's disease as well as amyotrophic lateral sclerosis. Utility of these systems broadly correlates with evolutionary complexity: small animal models such as rodents and the fruit fly are appropriate for pharmacological modeling and cognitive/behavioral assessment, the roundworm

Identifiers

PMID28031870
PMCPMC5137865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.